NDC 55289-736-15 - SKELAXIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-736
- Requested NDC
- 55289-736-15
- Package NDCs from labels
- 55289-736-10, 55289-736-20, 55289-736-21, 55289-736-30, 55289-736-40, 55289-736-15
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2022-05-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SKELAXIN ® (Metaxalone) Tablets | PD-Rx Pharmaceuticals, Inc. | 2022-05-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-736-10 | EA - Each | 55289-736 | 743913e9-15eb-4911-b515-cc6166f7b8f3 | 1 | 2013-02-13 |
| 55289-736-15 | EA - Each | 55289-736 | 64c1cde6-a385-4a0f-b31d-30ff077854bd | 1 | 2013-02-13 |
| 55289-736-20 | EA - Each | 55289-736 | 2fd96553-2c44-4360-a497-aad934db63a9 | 1 | 2013-02-13 |
| 55289-736-21 | EA - Each | 55289-736 | 78b86e17-6594-43c8-8fff-e22f986a14a6 | 1 | 2013-02-13 |
| 55289-736-30 | EA - Each | 55289-736 | cb700729-2c9c-4aa9-99e6-da9afec9375e | 1 | 2013-02-13 |
| 55289-736-40 | EA - Each | 55289-736 | ef00f0a0-9381-43da-8c86-02cf171bac2c | 1 | 2013-03-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METAXALONE | ACTIVE INGREDIENT | 1NMA9J598Y | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| METAXALONE | ACTIVE MOIETY | 1NMA9J598Y | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| ALGINIC ACID | INACTIVE INGREDIENT | 8C3Z4148WZ | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| CALCIUM | INACTIVE INGREDIENT | SY7Q814VUP | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metaxalone | METAXALONE | PD-Rx Pharmaceuticals, Inc. | 98713a2b-6666-44ea-9966-54e78041d27a | 2026-09-02 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | REMEDYREPACK INC. | fe82b33b-2a24-4477-91ca-b23e59156675 | 2026-08-26 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Preferred Pharmaceuticals Inc. | 01199953-8124-4ace-947f-7b11989b44c3 | 2026-07-24 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | REMEDYREPACK INC. | e9e45029-b1a4-435f-b9ca-cdfa01051bc8 | 2026-06-30 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Preferred Pharmaceuticals, Inc. | 1541da6a-7681-40bc-b67e-28e02a950d72 | 2026-06-17 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Preferred Pharmaceuticals Inc. | 8aa84e64-0075-4f22-a576-da085f32d56c | 2026-06-17 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | St. Mary's Medical Park Pharmacy | 5de36266-3964-5aca-e053-2991aa0a2205 | 2026-06-09 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Direct_Rx | 8c3bc0a2-5c93-e1d6-e053-2995a90a0b83 | 2026-05-11 | Warnings, Adverse reactions | 1NMA9J598Y |
| METAXALONE | METAXALONE | DIRECT RX | 9b7b4fc3-3f38-db66-e053-2995a90aaadb | 2026-05-11 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Direct_Rx | 91432cd0-8404-8029-e053-2a95a90adc1b | 2026-05-11 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | St. Mary's Medical Park Pharmacy | a23ca660-b066-1396-e053-2a95a90a30b2 | 2026-05-05 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Highmark Pharma LLC | 834be129-cfb5-4420-b660-025833376b3e | 2026-04-29 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Asclemed USA, Inc. | f4a0e910-2b20-46d4-b49e-21fb15925b58 | 2026-04-17 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Advanced Rx of Tennessee, LLC | 4facde6f-1828-9138-e063-6294a90a1ec1 | 2026-04-17 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | AvKARE | 4c3b2aa4-fe65-507c-e063-6394a90a7b00 | 2026-03-17 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | AvKARE | 4c3ae824-48a9-fd91-e063-6394a90a9a54 | 2026-03-04 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Sportpharm LLC | 5bcdc9d3-8827-4d05-8783-4519f1b284a3 | 2026-02-03 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | INA Pharmaceutics Inc | fc6de1a6-26aa-47ac-a5d2-bf127a6ca563 | 2026-02-03 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Direct_Rx | 45726fbc-3450-63f7-e063-6394a90a671a | 2026-01-14 | Warnings, Adverse reactions | 1NMA9J598Y |
| METAXALONE | METAXALONE | DIRECT RX | 49250bbf-fbfe-07cd-e054-00144ff88e88 | 2026-01-08 | Warnings, Adverse reactions | 1NMA9J598Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.